Randomized phase II study of recombinant human endostatin combined with definitive chemoradiotherapy in locally advanced esophageal squamous cell carcinoma.

Jiahua Lv(University of Electronic Science and Technology of China), Junchao Wang(Wuhan University), Tao Li(Zhejiang Normal University), Li Fang(Hunan Cancer Hospital), Churong Li(Sichuan Cancer Hospital), Yanqiong Song(University of Electronic Science and Technology of China), Xiaorong Deng(Nanchang University)
Journal of Clinical Oncology
May 20, 2015
Cited by 4


Related Papers